JNJ
JOHNSON & JOHNSON
Healthcare • CIK 0000200406
Loading...
Market Cap
$613.70B
P/E (TTM)
29.1x
Rev Growth (TTM)
+8.1%
Net Margin (TTM)
21.5%
FCF Yield (TTM)
3.6%
FCF Margin (TTM)
22.7%
Filings
Primary-source SEC disclosures, read end-to-end — every figure traceable to its filing.
8-KAug 20262026-08-04source
8-KJul 20262026-07-29source
8-KJul 20262026-07-28source
10-Q2026 Q22026-07-23source
8-KEarnings2026-07-15source
What your agent reads
Investor Relations
Company-published material — management’s own words, not SEC-audited. Each source below is labeled so your agent knows what to verify.
Company-published, not SEC-audited
Earnings
Q2
about 1 month ago
8-K releaseRevenue
$25.31B
+6.6%
Net Income
$5.53B
-0.1%
EPS
N/A
—
Most recent quarterly earnings snapshot
Cash Flow Health
Free Cash Flow8/8 positive
TTM$22.2B
Q2 '26
$7.3B+398%
Q1 '26
$1.5B-73%
FCF Margin
TTM22.7%
Q2 '2628.8%+373%
Sector: 0.0%Top 10%
OCF Margin28.2%
OCF/NI1.31x
CapEx Coverage5.1x
FCF Yield3.6%
FCF Growth (2Y)+15%
Cash Conversion Cycle
112 days
DSO: 66+DIO: 166−DPO: 120
Cash flow trends & capital efficiency
Capital Allocation
Total Shareholder YieldTTM
TTM3.4%
Div Yield2.1%
+Buyback (TTM)1.3%
Dividend & Payout Metrics
Dividend Yield (TTM)2.1%
FCF Payout Ratio56.8%
Free Cash Flow (TTM)$22.2B
Stock Repurchases (TTM)$8.1B
Capital Return / FCF93.0%
Est. Dividends Paid (TTM)$12.6B
Shows how management rewards shareholders
Valuation Metrics
Price-to-EarningsTTM
29.1x
Volatile
8Q: 24.9x+29%
Multiple expansion without fundamental improvement
High PEG ratio (3.6x) suggests expensive for growth
Valuation Lenses
Earnings
29.1x
vs – sector
Cash Flow
23.8x
EV/FCF vs –
Growth-Adj
3.6xPEG
Expensive for growth
Quality-Adj
1.7P/E per %ROIC
ROIC: 16.8%
Shareholder Returns
Dividend
2.1%
Buyback
1.3%
Total Yield
3.4%
Market Cap$613.70B
EV$641.98B
Multi-angle valuation analysis with sector context
Margins & Efficiency
ROIC 75th pctile
Profitability Cascade
Gross
67.9%
Operating
26.8%
Top 25% in sector
Net
21.5%
Margins Unknown
Return on Invested CapitalTTM
16.8%
Stable
+0.0% YoY-0.9%
P25MedianP75
75th pctl (med: -0.1%)
DuPont BreakdownROIC = Margin × Turn × (1+D/E)
NOPAT Margin
22.4%
8Q: 23.2%
Asset Turnover
0.50x
8Q: 0.50x
Leverage (1+D/E)
1.58x
D/E: 0.58x
DuPont: 17.5% ≈ 16.8% ROIC
Asset & CapEx Efficiency
Fixed Asset Turn
4.28x
8Q:4.33x
-17.7%
Invested Cap Turn
0.79x
8Q:0.80x
-3.5%
CapEx Intensity
4.4%
8Q:3.8%
CapEx/Depreciation
0.69x
FCF vs Net Margin Gap+1.2 pts
Margin trends, ROIC, and capital efficiency
Balance Sheet & Solvency
D/E 0.58x
Net Debt / EBITDA
–Net Debt: $28.28B
Interest Coverage
–
Leverage Metrics
Debt-to-Equity
0.58x
Balance sheet risk & solvency analysis